Cyclic AMP: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
No edit summary
imported>Robert Badgett
No edit summary
Line 3: Line 3:


Cyclic AMP, along with pyrophasphate, are formed by action of the enzyme [[adenylate cyclase]] on [[adenosine triphosphate]] (ATP).
Cyclic AMP, along with pyrophasphate, are formed by action of the enzyme [[adenylate cyclase]] on [[adenosine triphosphate]] (ATP).
The [[medication]] [[adenosine]] inhibits the effects intracellular [[cyclic AMP]] thus reducing [[sympathetic nervous system|sympathetic]] stimulation.<ref name="isbn0-07-142280-3">{{cite book |author=Keith Parker; Laurence Brunton; Goodman, Louis Sanford; Lazo, John S.; Gilman, Alfred |authorlink= |editor= |others= |title=Goodman & Gilman's the pharmacological basis of therapeutics |edition=11th |language=|chapter=Chapter 34. Antiarrhythmic Drugs |publisher=McGraw-Hill |location=New York |year=2006 |origyear= |pages= |quote= |isbn=0-07-142280-3 |oclc= |doi= |url= |accessdate=}}</ref>


==References==
==References==
<references/>
<references/>

Revision as of 20:49, 15 July 2008

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In biochemistry, cyclic AMP is an "adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH."[1]

Cyclic AMP, along with pyrophasphate, are formed by action of the enzyme adenylate cyclase on adenosine triphosphate (ATP).

The medication adenosine inhibits the effects intracellular cyclic AMP thus reducing sympathetic stimulation.[2]

References

  1. Anonymous (2024), Cyclic AMP (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. Keith Parker; Laurence Brunton; Goodman, Louis Sanford; Lazo, John S.; Gilman, Alfred (2006). “Chapter 34. Antiarrhythmic Drugs”, Goodman & Gilman's the pharmacological basis of therapeutics, 11th. New York: McGraw-Hill. ISBN 0-07-142280-3.